Anna Esbensen, PhD, is an associate professor of pediatrics at the University of Cincinnati College of Medicine in the Division of Developmental and Behavioral Pediatrics at Cincinnati Children’s Hospital Medical Center. She studies the lifespan development of individuals with Down syndrome and provides clinical services to families of children with Down syndrome.
Peter K. Todd, M.D., Ph.D., is the Bucky and Patti Harris Professor and Associate Chair of research in the Department of Neurology in the University of Michigan Medical School. Todd’s lab studies the mechanisms by which nucleotide repeat expansions cause neurological disorders with a long term goal of developing novel therapeutics for these currently untreatable conditions.
Julie Lounds Taylor, Ph.D. is the Transitions Lab Principal Investigator (PI) and lab director. She is an associate professor of pediatrics at Vanderbilt University Medical Center, and an investigator at the Vanderbilt Kennedy Center for Research on Human Development. A major focus of Taylor’s research is on factors that promote a positive transition into adulthood for individuals with developmental disabilities, in particular those with autism spectrum disorder.
Most infants and toddlers have a prodigious ability to learn, in part because they spend a lot of time interacting with caregivers. In the Princeton Baby Lab, we study how the mechanisms of infant cognition and the details of environmental experience combine to shape early learning. In particular, we study the beginnings of language learning and communication.
Dr. Meyer is associate professor of medical and molecular genetics at Indiana University School of Medicine, with adjunct appointments in ophthalmology and the Stark Neurosciences Research Institute. His research focuses upon the differentiation of retinal ganglion cells from human pluripotent stem cells, including the derivation of glaucoma models through iPS cell reprogramming as well as Crispr/Cas9 gene editing. Ongoing projects in his lab explore the use of these cells for studies of RGC development as well as mechanisms underlying glaucomatous neurodegeneration.
Dr. Wu is a magnetic resonance imaging physicist by training. Her research focuses on diffusion physics in biologic system using diffusion MRI. She started to work on diffusion MRI extensively in her graduate education. She continued to advance in this field independently at Dartmouth College (2009-2013) and currently at Indiana University School of Medicine.
Dr. Bishop is an associate Professor in the Department of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences at UCSF. She is a clinical psychologist with expertise in assessment, diagnosis, and treatment of individuals with autism spectrum disorders. Her research and clinical interests are focused on ASD symptom manifestations in individuals of different ages and levels of ability, as well as on differentiating between ASD and other developmental disabilities across the lifespan.
Dr. Harding is a professor in the Departments of Molecular and Medical Genetics and Pediatrics at Oregon Health & Science University (OHSU). He is an attending physician on the OHSU clinical genetics service, the clinical genetics clinic, and the metabolic clinic at Doernbecher Children's Hospital and the medical director of the biochemical genetics laboratory in the Knight Diagnostic Laboratories at OHSU. Harding's basic and clinical research programs are focused upon the development of novel therapies, including gene and cell therapies, for inborn errors of metabolism.